NIDDM: A rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment

Diabetologia

Volumn 39, Issue 12, 1996, Pages 1629-1633

  Birkeland, K I ^a   Rishaug, U ^a   Hanssen, K F ^a   Vaaler, S ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

insulin treatment; metabolic control; sulphonylurea treatment

Indexed keywords

GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFICACY; FEMALE; HUMAN; HYPERGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; MIDDLE AGED; SULFONYLUREA COMPOUNDS; TIME FACTORS;

EID: 0029908110     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050626     Document Type: Conference Paper

References (23)

1. Klein R, Klein BEK, Moss SE, Cruickshanks KJ (1994) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 107: 244-249
2. Klein R, Klein BEK, Moss SE, Cruickshanks KJ (1995) Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 44: 916-923
3. Klein R (1995) Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18: 258-268
4. Uusitupa MIJ, Niskanan LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and nondiabetic subjects. Diabetologia 36: 1175-1184
5. Malmberg K, Rydén L, Efendic S et al. (1995) Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26: 57-65
6. Andersson DKG, Svärdsudd K (1995) Long-term glycemic control relates to mortality in type 2 diabetes. Diabetes Care 18: 1534-1543
7. Multi-centre Study (1983) UK Prospective Study of Therapies of Maturity-Onset Diabetes. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia 24: 404-411
8. Hadden DR, Blair ALT, Wilson EA (1986) Natural history of diabetes presenting at age 40-69 years: a prospective study of the influence of intensive dietary therapy. Q J Med 59: 574-598
9. Niskanen L, Karjalainen J, Sitonen O, Uusitupa M (1994) Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J Intern Med 36: 263-270
10. United Kingdom Prospective Diabetes Study (1995) (UK-PDS) 13 relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 310: 83-88
11. UK prospective diabetes study group. UK prospective diabetes study 16 (1995) Overview of 6 years' therapy of type 2 diabetes: a progressive disease. Diabetes 44: 1249-1258
12. Birkeland KI, Hanssen KF, Urdal P, Berg K, Vaaler S (1994) A long-term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes. J Intern Med 236: 305-313
13. Marble A (1962) Incidence and causes of secondary failure in treatment with tolbutamide: experience with 2500 patients treated up to 5 years. JAMA 181:1-4
14. Haupt E, Laube F, Loy H, Schöffling K (1977) Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides. Med Klin 72: 1529-1536
15. Groop L, Schalin C, Franssila-Kallunki A, Widén E, Ekstrand A, Eriksson J (1989) Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy. Am J Med 87: 183-190
16. Clauson P, Linnarsson R, Gottsäter A, Sundkvist G, Grill V (1994) Relationships between diabetes duration, metabolic control and b-cell function in a representative population of type 2 diabetic patients in Sweden. Diabet Med 11: 794-801
17. Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15: 815-819
18. Birkeland KI, Chatzipanagiotou F, Hanssen KF, Vaaler S (1992) Relationship between blood pressure and in vivo action of insulin in type II (non-insulin-dependent) diabetic subjects. Metabolism 41: 301-305
19. Lidström T, Arnqvist HJ, Olsson AG (1990) Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 81: 137-144
20. Stern MP, Mitchell BD, Haffner SM, Hazuda HP (1992) Does glycaemic control of type 2 diabetes suffice to control diabetic dyslipidaemia. Diabetes Care 15: 638-644
21. Lillioja S, Mott DK, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217-1225
22. Yki-Järvinen H (1990) Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia 33: 579-585
23. Unger RH, Grundy S (1995) Hyperglycaemia as an inducer as well as consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119-121